Owlet Inc (OWLT) Stock Analysis — PE Ratio, PS Ratio, Intrinsic Value & 2030 Price Target
Owlet Inc stock (OWLT) is currently trading at $5.11. Owlet Inc PS ratio (Price-to-Sales) is 1.42. Analyst consensus price target for OWLT is $14.25. WallStSmart rates OWLT as Sell.
- OWLT PE ratio analysis and historical PE chart
- OWLT PS ratio (Price-to-Sales) history and trend
- OWLT intrinsic value — DCF, Graham Number, EPV models
- OWLT stock price prediction 2025 2026 2027 2028 2029 2030
- OWLT fair value vs current price
- OWLT insider transactions and insider buying
- Is OWLT undervalued or overvalued?
- Owlet Inc financial analysis — revenue, earnings, cash flow
- OWLT Piotroski F-Score and Altman Z-Score
- OWLT analyst price target and Smart Rating
Owlet Inc
📊 No data available
Try selecting a different time range
Smart Analysis
Owlet Inc (OWLT) · 8 metrics scored
Smart Score
Category Performance
WallStSmart pulls financial metrics like revenue growth, profit margins, and valuation ratios and scores each one from 0 to 10 based on how strong or weak it is. Those 10 scores are grouped into 4 categories: Growth, Profitability, Valuation, and Quality — which form the 4 axes of the spider chart you see. The categories are then combined into a final score out of 100, but not equally. Growth and Profitability together count for 60% of the total, because a fast-growing profitable business matters more than just a cheap one. That final number maps to a rating (Strong Buy, Buy, Hold, Avoid) and a letter grade, giving you one clear Stock Rating.
Investment Thesis
Strong fundamentals in price/sales, revenue growth, institutional own.. Concerns around market cap and return on equity. Significant fundamental concerns warrant caution or avoidance.
Owlet Inc (OWLT) Key Strengths (3)
71.33% of shares held by major funds and institutions
Paying $1.42 for every $1 of annual revenue
Strong revenue growth at 29.60% annually
Supporting Valuation Data
Owlet Inc (OWLT) Areas to Watch (5)
Company is destroying shareholder value
Losing money on operations
Company is losing money with a negative profit margin
Very expensive at 6.4x book value
Micro-cap company with very limited liquidity and high volatility
Owlet Inc (OWLT) Detailed Analysis Report
Overall Assessment
This company scores 30/100 in our Smart Analysis, earning a F grade. Out of 8 metrics analyzed, 3 register as strengths (avg 8.7/10) while 5 fall into concern territory (avg 1.0/10). The category breakdown reveals uneven performance, with some areas requiring attention.
The Bull Case
The strongest argument centers on Institutional Own., Price/Sales, Revenue Growth. Valuation metrics including Price/Sales (1.42) suggest the stock is attractively priced. Growth metrics are encouraging with Revenue Growth at 29.60%.
The Bear Case
The primary concerns are Return on Equity, Operating Margin, Profit Margin. Some valuation metrics including Price/Book (6.41) suggest expensive pricing. Profitability pressure is visible in Return on Equity at -802.00%, Operating Margin at -18.40%, Profit Margin at -37.50%.
Key Dynamics to Monitor
Three factors to monitor going forward. First, whether Return on Equity improves, as this is the primary drag on the overall score. Second, margin trajectory, with Return on Equity at -802.00% needing improvement to support the investment thesis. Third, growth sustainability, with Revenue Growth at 29.60% strong but requiring continuation.
Risk Considerations
Based on the metric profile, this is a higher risk investment. There are more areas of concern than strength, warranting a more conservative position size. Investors should size positions according to their risk tolerance and maintain diversification.
Bottom Line
Fundamental challenges outweigh strengths at current levels. Return on Equity and Operating Margin are the primary drags. Consider waiting for meaningful improvement before committing capital.
Disclaimer: Smart Analysis is a scoring system developed by WallStSmart Team. Scores update daily using multi-model valuation framework. Always conduct your own research and consult with financial advisors before making investment decisions.
OWLT Price-to-Sales(PS) Ratio Chart
Historical valuation based on market cap ÷ trailing 12-month revenue
OWLT's Price-to-Sales ratio of 1.42x trades 31% below its historical average of 2.05x (14th percentile). The current valuation is 57% below its historical high of 3.28x set in Mar 2026, and 2% above its historical low of 1.4x in Mar 2026. Over the past 12 months, the PS ratio has compressed from ~3.2x as trailing revenue scaled faster than the stock price.
WallStSmart Analysis Synopsis
Data-driven financial summary for Owlet Inc (OWLT) · HEALTHCARE › MEDICAL DEVICES
The Big Picture
Owlet Inc is a strong growth company balancing expansion with improving profitability. Revenue reached 106M with 30% growth year-over-year. The company is currently unprofitable, posting a -37.5% profit margin.
Key Findings
Revenue growing at 30% YoY, reaching 106M. This pace significantly outperforms most MEDICAL DEVICES peers.
The company is unprofitable with a -37.5% profit margin. The path to breakeven will be the key catalyst.
Free cash flow is -453,000, meaning the company is burning cash. This may be acceptable for high-growth companies investing heavily.
What to Watch Next
Growth sustainability: can Owlet Inc maintain 30%+ revenue growth, or will competition slow it down?
Volatility is elevated with a beta of 1.74, so expect amplified moves relative to the broader market.
Sector dynamics: monitor MEDICAL DEVICES industry trends, competitive moves, and regulatory changes that could impact Owlet Inc.
Bottom Line
Owlet Inc offers an attractive blend of growth (30% revenue expansion) and improving fundamentals. The company is transitioning from pure growth to profitable growth, a critical inflection point. Watch for sustained margin expansion as the key signal.
This synopsis is generated from publicly available financial data. It is not financial advice. Always conduct your own research and consult a qualified financial advisor before making investment decisions.
Insider Transactions
Loading insider activity...
About Owlet Inc(OWLT)
NYSE
HEALTHCARE
MEDICAL DEVICES
USA
Owlet Inc. is a pioneering leader in infant health technology, dedicated to improving the safety and well-being of newborns through innovative monitoring solutions. Its flagship product, the Owlet Smart Sock, utilizes advanced pulse oximetry to provide continuous tracking of infants' heart rates and oxygen levels, offering critical health insights directly to parents' mobile devices. As the demand for pediatric health monitoring continues to rise, Owlet is well-equipped to expand its product offerings and enhance its market position in the rapidly evolving infant health sector. By prioritizing actionable data for parents and advancing pediatric care, Owlet is establishing a significant presence at the convergence of healthcare and technology.